AVMA warns against further restrictions on cephalosporin utilization in food animals that aren’t backed by science The American Veterinary Medical Association announced today that the FDA’s order prohibiting specific uses of cephalosporins in food animals appears consistent with the current AVMA position on the limited prohibition on extra-label drug use, but warned against further restrictions not backed by science. Cephalosporins, a course of antimicrobial drug used in livestock, poultry and other food-producing animals, are also commonly found in humans to take care of pneumonia and a wide range of skin and gentle tissue infections, urinary tract attacks and inflammatory disease More information here . The FDA stated it is limiting the use of cephalosporins in pets to preserve the potency of the medications for dealing with disease in humans and reduce the threat of cephalosporin resistance using bacterial pathogens.
To find out more, please visit.. AVEO commences enrollment in tivozanib Phase 2 study in renal cell carcinoma AVEO Pharmaceuticals, Inc. today announced that it provides initiated patient enrollment in a multi-center Phase 2 exploratory biomarker study of tivozanib, its lead product candidate made to optimally block the VEGF pathway by inhibiting all three VEGF receptors, in patients with renal cell carcinoma .D., senior vice president, translational medication at AVEO. ‘AVEO is normally focused on advancing the technology behind biomarkers and individual treatment approaches. The advancement and identification of relevant biomarkers is a strategic element of our drug advancement efforts.